Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SurModics Inc (NASDAQ:SRDX)

Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
Today|||52-Week Range
Health Technology
Medical Specialties

Company Description

SurModics, Inc. provides surface modification and in vitro diagnostic technologies to the healthcare industry. The company offers surface modification coating technologies and components for in vitro diagnostic test kits and microarrays. It operates through two segments: Medical Device and In Vitro Diagnostics. The Medical Device segment engages in contract research and development, as well as manufacturing of balloons catheters used for a variety of interventional cardiology applications. The In Vitro Diagnostics segment manufactures or sells components for in vitro diagnostic immunoassay and molecular tests. SurModics was founded in June 1979 and is headquartered in Eden Prairie, MN.

Contact Information

SurModics, Inc.
9924 West 74th Street
Eden Prairie Minnesota 55344-3523
P:(952) 500-7000
Investor Relations:



Other institutional51.64%
Individual stakeholders43.57%
Mutual fund holders34.16%

Top Executives

Gary R. MaharajPresident, Chief Executive Officer & Director
Andrew D. C. LaFrenceChief Financial Officer & Accounting Officer
Gregg S. SuttonVice President-Research & Development
Joseph J. StichVice President & GM-In Vitro Diagnostics
Charles W. OlsonSVP-Commercial & Business Development